Photo: ABP News
Glenmark Launches Nitric Oxide Nasal Spray For COVID-19 Patients In India
Amid COVID-19 pandemic, India is to have Nitric Oxide Nasal Spray, for adults having the infection. Launched on February 9 by Glenmark Pharmaceutical, the spray would be for adults, contracting the virus, with high-risk of progression of the disease. The medicine has been launched under FabiSpray brand in India. In July 2021, Glenmark proposed the nasal Spray, which later got approved by the Drugs Controller Genera of India (DCGI).
Tags: Covid-19, Nasal Spray, glenmark pharmaceuticals, Central Government, DCGI
Courtesy: The Free Press Journal
Photo: The Logical Indian
Adding Umifenovir Doesn't Enhance Efficacy Of Favipiravir Drug Regimen
Adding antiviral Umifenovir in Favipiravir drug regimen does not enhance the effectiveness of the latter, asserted Glenmark Pharmaceuticals on October 9. Reportedly, the pharmaceutical company had conducted clinical trials to determine the efficacy of addition of Umifenovir against mono-therapy of Favipiravir tablets. Earlier, Glenmark had conducted clinical trials to determine the use of Favipiravir for COVID-19 treatment and had eventually… read-more
Tags: glenmark pharmaceuticals, Covid-19, coronavirus treatment, Favipiravir
Courtesy: The Economic Times
Photo: BioSpectrum India
Glenmark Pharmaceuticals Receives Approval For Multiple Sclerosis Drug
Glenmark Pharmaceuticals Inc., USA has informed that it has received the regulatory approvals for Dimethyl Fumarate delayed-release capsules by the US Food and Drug Administration (FDA). The capsules which have got approval for 120mg and 240mg, can be used for the treatment of relapsing forms of multiple sclerosis. Multiple sclerosis is a chronic illness of central nervous system that affects the brain, spinal cord, and optic nerves.
Tags: food and drug administration, sclerosis, drug, glenmark pharmaceuticals
Courtesy: The Economic Times
